DS STAGE III MULTIPLE MYELOMA
Clinical trials for DS STAGE III MULTIPLE MYELOMA explained in plain language.
Never miss a new study
Get alerted when new DS STAGE III MULTIPLE MYELOMA trials appear
Sign up with your email to follow new studies for DS STAGE III MULTIPLE MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Pill after transplant aims to keep blood cancer at bay
Disease control OngoingThis study tested whether taking a daily pill called lenalidomide after a stem cell transplant could help patients with multiple myeloma live longer without their cancer getting worse. About 460 patients who had their own stem cells transplanted were randomly assigned to receive …
Matched conditions: DS STAGE III MULTIPLE MYELOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Major cancer trial tests powerful new drug cocktail against blood cancer
Disease control OngoingThis large Phase 3 trial compares two different drug combinations for people newly diagnosed with multiple myeloma, a type of blood cancer. It tests whether adding a drug called bortezomib to a standard two-drug regimen (lenalidomide and dexamethasone) works better at controlling…
Matched conditions: DS STAGE III MULTIPLE MYELOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
Major cancer trial tests gentler treatment for blood cancer patients
Disease control OngoingThis large study compared two treatment approaches for newly diagnosed multiple myeloma, a blood cancer. Researchers tested whether a lower dose of one drug (dexamethasone) combined with lenalidomide works as well as the standard higher dose, with fewer side effects. Patients who…
Matched conditions: DS STAGE III MULTIPLE MYELOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC